Triggering final follicular maturation: hCG, GnRH-agonist, or both, when and to whom?
作者信息
Orvieto Raoul
机构信息
Infertility and IVF Unit, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center (Tel Hashomer), Ramat Gan and the Tarnesby-Tarnowski Chair for Family Planning and Fertility Regulation, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
出版信息
J Assist Reprod Genet. 2017 Sep;34(9):1231-1232. doi: 10.1007/s10815-017-0982-7. Epub 2017 Jun 27.
Abstract
摘要
相似文献
1
Triggering final follicular maturation: hCG, GnRH-agonist, or both, when and to whom?触发卵泡最终成熟：人绒毛膜促性腺激素、促性腺激素释放激素激动剂，或两者并用，何时使用及用于何人？
J Assist Reprod Genet. 2017 Sep;34(9):1231-1232. doi: 10.1007/s10815-017-0982-7. Epub 2017 Jun 27.
2
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.在拮抗剂辅助生殖技术周期中，促性腺激素释放激素激动剂与绒毛膜促性腺激素用于触发排卵的比较。
Cochrane Database Syst Rev. 2010 Nov 10(11):CD008046. doi: 10.1002/14651858.CD008046.pub2.
3
Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.促性腺激素释放激素激动剂和人绒毛膜促性腺激素双重触发可显著提高 GnRH 拮抗剂周期中正常反应者的活产率。
Fertil Steril. 2013 Nov;100(5):1296-302. doi: 10.1016/j.fertnstert.2013.07.1976. Epub 2013 Aug 28.
4
Dual triggering with GnRH agonist plus hCG versus triggering with hCG alone for IVF/ICSI outcome in GnRH antagonist cycles: a systematic review and meta-analysis.在GnRH拮抗剂周期中，GnRH激动剂联合hCG双重触发与单独使用hCG触发对体外受精/卵胞浆内单精子注射结局的影响：一项系统评价和荟萃分析。
Arch Gynecol Obstet. 2018 Jul;298(1):17-26. doi: 10.1007/s00404-018-4751-3. Epub 2018 Mar 29.
5
A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.对于有卵巢过度刺激综合征风险且正在接受控制性卵巢刺激的患者，采用促性腺激素释放激素激动剂触发排卵并积极进行黄体期支持。
Taiwan J Obstet Gynecol. 2015 Oct;54(5):583-7. doi: 10.1016/j.tjog.2015.08.012.
6
Triggering final follicular maturation-hCG, GnRH-agonist or both, when and to whom?触发最终卵泡成熟——人绒毛膜促性腺激素、促性腺激素释放激素激动剂或两者兼用，何时使用以及用于何人？
J Assist Reprod Genet. 2016 Oct;33(10):1415-1416. doi: 10.1007/s10815-016-0775-4. Epub 2016 Jul 22.
7
Comparison of dual trigger with combination GnRH agonist and hCG versus hCG alone trigger of oocyte maturation for normal ovarian responders.比较双重触发与 GnRH 激动剂和 hCG 联合与单独使用 hCG 触发正常卵巢反应者卵母细胞成熟的效果。
Int J Gynaecol Obstet. 2018 Jun;141(3):327-331. doi: 10.1002/ijgo.12457. Epub 2018 Feb 21.
8
Levels of the epidermal growth factor-like peptide amphiregulin in follicular fluid reflect the mode of triggering ovulation: a comparison between gonadotrophin-releasing hormone agonist and urinary human chorionic gonadotrophin.卵泡液中表皮生长因子样肽 Amphiregulin 的水平反映了诱发排卵的方式：促性腺激素释放激素激动剂与尿促性腺激素的比较。
Fertil Steril. 2011 May;95(6):2034-8. doi: 10.1016/j.fertnstert.2011.02.013. Epub 2011 Mar 5.
9
Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve.双重触发：促性腺激素释放激素激动剂联合人绒毛膜促性腺激素显著提高卵巢储备功能减退患者的活产率。
Reprod Biol Endocrinol. 2019 Jan 4;17(1):7. doi: 10.1186/s12958-018-0451-x.
10
GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.促性腺激素释放激素激动剂（布舍瑞林）或人绒毛膜促性腺激素用于促性腺激素释放激素拮抗剂体外受精/卵胞浆内单精子注射周期的排卵诱导：一项前瞻性随机研究。
Hum Reprod. 2005 May;20(5):1213-20. doi: 10.1093/humrep/deh765. Epub 2005 Mar 10.
引用本文的文献
1
FSH/LH co-stimulation in Advanced Maternal Age (AMA) and hypo-responder patients - Arabian gulf delphi consensus group.高龄产妇（AMA）和低反应患者中的促卵泡生成素/促黄体生成素联合刺激——阿拉伯湾德尔菲共识小组
Front Endocrinol (Lausanne). 2024 Dec 12;15:1506332. doi: 10.3389/fendo.2024.1506332. eCollection 2024.
2
GnRH Agonist versus hCG Trigger in Ovulation Induction with Intrauterine Insemination: A Randomized Controlled Trial.GnRH激动剂与hCG触发用于宫内人工授精诱导排卵的随机对照试验
Int J Endocrinol. 2019 Mar 13;2019:2487067. doi: 10.1155/2019/2487067. eCollection 2019.
3
Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.在体外受精治疗中诱导卵母细胞最终成熟的新概念。
Endocr Rev. 2018 Oct 1;39(5):593-628. doi: 10.1210/er.2017-00236.
本文引用的文献
1
Combined GnRH-agonist and human chorionic gonadotropin trigger improves ICSI cycle outcomes in patients with history of poor fertilization.促性腺激素释放激素激动剂与人绒毛膜促性腺激素联合触发改善受精不良病史患者的卵胞浆内单精子注射周期结局。
J Assist Reprod Genet. 2017 Jun;34(6):781-788. doi: 10.1007/s10815-017-0917-3. Epub 2017 Apr 13.
2
A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.一种简化的体外受精促排卵方案通用方法：采用定制的最终卵泡成熟模式和时间的超短激动剂/拮抗剂联合方案。
J Ovarian Res. 2015 Nov 4;8:69. doi: 10.1186/s13048-015-0198-3.
3
Triggering final follicular maturation--hCG, GnRH-agonist or both, when and to whom?触发卵泡最终成熟——人绒毛膜促性腺激素、促性腺激素释放激素激动剂还是两者并用，何时使用以及适用于何人？
J Ovarian Res. 2015 Aug 21;8:60. doi: 10.1186/s13048-015-0187-6.
4
Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes.对于成熟卵母细胞比例较低的患者，联合使用促性腺激素释放激素激动剂（GnRH-agonist）和人绒毛膜促性腺激素（hCG）进行最终卵母细胞成熟（双重触发）。
Gynecol Endocrinol. 2015 Feb;31(2):145-7. doi: 10.3109/09513590.2014.978850. Epub 2014 Nov 11.
5
Co-administration of GnRH-agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles--a preliminary report.在每个排卵前卵泡中获取的卵母细胞数量较少的患者中，联合使用促性腺激素释放激素激动剂（GnRH-agonist）和人绒毛膜促性腺激素（hCG）进行最终卵母细胞成熟（双重触发）——初步报告。
J Ovarian Res. 2014 Aug 2;7:77. doi: 10.1186/1757-2215-7-77.
6
Empty follicle syndrome: successful treatment in a recurrent case and review of the literature.空卵泡综合征：1 例复发性病例的成功治疗及文献复习
Hum Reprod. 2012 May;27(5):1357-67. doi: 10.1093/humrep/des037. Epub 2012 Feb 21.
Zotero 插件